Middle East Journal of Rehabilitation and Health Studies

Published by: Kowsar
Crossmark
Uncorrected Proof scheduled for 6 (3)

Assessment of SHV, CTX-M, and IMP Genes in Beta-Lactam-Resistant Escherichia coli Isolated from Patients with Urinary Tract Infection

Anna Abdolshahi 1 , Zahra Aminian 1 , Tahereh Zinati 1 , Aliakbar Shabani 1 , * , Mehrdad Khaledi 1 and Vajiheh Zarrinpour 1
Authors Information
1 Semnan University of Medical Sciences, Semnan, Iran
Article information
  • Middle East Journal of Rehabilitation and Health Studies: In Press (In Press); e88524
  • Published Online: July 7, 2019
  • Article Type: Research Article
  • Received: December 31, 2018
  • Revised: May 18, 2019
  • Accepted: June 1, 2019
  • DOI: 10.5812/mejrh.88524

To Cite: Abdolshahi A, Aminian Z , Zinati T , Shabani A, Khaledi M , et al. Assessment of SHV, CTX-M, and IMP Genes in Beta-Lactam-Resistant Escherichia coli Isolated from Patients with Urinary Tract Infection, Middle East J Rehabil Health Stud. Online ahead of Print ; In Press(In Press):e88524. doi: 10.5812/mejrh.88524.

Abstract
Copyright © 2019, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Toval F, Kohler CD, Vogel U, Wagenlehner F, Mellmann A, Fruth A, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014;52(2):407-18. doi: 10.1128/JCM.02069-13. [PubMed: 24478469]. [PubMed Central: PMC3911323].
  • 2. Hojati Z, Zamanzad B, Hashemzadeh M, Molaie R, Gholipour A. The fimh gene in uropathogenic Escherichia coli strains isolated from patients with urinary tract infection. Jundishapur J Microbiol. 2015;8(2). e17520. doi: 10.5812/jjm.17520. [PubMed: 25825648]. [PubMed Central: PMC4376967].
  • 3. Tasli H, Bahar IH. Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis. 2005;58(3):162-7. [PubMed: 15973008].
  • 4. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11):1193-204. doi: 10.1001/jama.2016.11764. [PubMed: 27654605].
  • 5. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-18. doi: 10.1179/2047773215Y.0000000030. [PubMed: 26343252]. [PubMed Central: PMC4768623].
  • 6. Kadaei V, Rashki A. Antibiotic resistance pattern and genotype of beta-lactamase producing Escherichia coli isolates from urinary tract infections in zabol-souteast of Iran. J Med Microbiol Infect Dis. 2014;2(4):153-8.
  • 7. McCracken M, DeCorby M, Fuller J, Loo V, Hoban DJ, Zhanel GG, et al. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: Results from CANWARD 2007. J Antimicrob Chemother. 2009;64(3):552-5. doi: 10.1093/jac/dkp225. [PubMed: 19578083].
  • 8. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54(3):969-76. doi: 10.1128/AAC.01009-09. [PubMed: 19995920]. [PubMed Central: PMC2825993].
  • 9. Rawat D, Nair D. Extended-spectrum beta-lactamases in Gram Negative Bacteria. J Glob Infect Dis. 2010;2(3):263-74. doi: 10.4103/0974-777X.68531. [PubMed: 20927289]. [PubMed Central: PMC2946684].
  • 10. Bajpai T, Pandey M, Varma M, Bhatambare GS. Prevalence of TEM, SHV, and CTX-M Beta-Lactamase genes in the urinary isolates of a tertiary care hospital. Avicenna J Med. 2017;7(1):12-6. doi: 10.4103/2231-0770.197508. [PubMed: 28182026]. [PubMed Central: PMC5255976].
  • 11. Allam B, Paillard C, Auffret M, Ford SE. Effects of the pathogenic Vibrio tapetis on defence factors of susceptible and non-susceptible bivalve species: II. Cellular and biochemical changes following in vivo challenge. Fish Shellfish Immunol. 2006;20(3):384-97. doi: 10.1016/j.fsi.2005.05.013. [PubMed: 16005645].
  • 12. Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90-101. doi: 10.1016/j.sjbs.2014.08.002. [PubMed: 25561890]. [PubMed Central: PMC4281622].
  • 13. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev. 2005;18(4):657-86. doi: 10.1128/CMR.18.4.657-686.2005. [PubMed: 16223952]. [PubMed Central: PMC1265908].
  • 14. Habeeb MA, Sarwar Y, Ali A, Salman M, Haque A. Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan. Pak J Med Sci. 2013;29(2):540-4. doi: 10.12669/pjms.292.3144. [PubMed: 24353573]. [PubMed Central: PMC3809246].
  • 15. Boisen N, Struve C, Scheutz F, Krogfelt KA, Nataro JP. New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family. Infect Immun. 2008;76(7):3281-92. doi: 10.1128/IAI.01646-07. [PubMed: 18443096]. [PubMed Central: PMC2446688].
  • 16. Soltan Dallal M, Sabbaghi A, Molla Aghamirzaeie H, Rastegar Lari A, Eshraghian MR, Fallah Mehrabad J, et al. Prevalence of AmpC and SHV β-lactamases in clinical isolates of Escherichia coli From Tehran hospitals. Jundishapur J Microbiol. 2013;6(2). doi: 10.5812/jjm.5043.
  • 17. Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009;15(1):37-9. doi: 10.1089/mdr.2009.0880. [PubMed: 19265477].
  • 18. Haghighat Panah M, Amirmozafari. N , Faezi M, Shenagari M. [Surveying of antibiotic resistance pattern and frequency rate of blaTEM in the ESBLs producing E. coli isolated in Rasht]. Sci J Ilam Univ Med Sci. 2014;22(4):180-9. Persian.
  • 19. Antunes F, Hinzmann M, Lopes-Lima M, Vaz-Pires P, Ferreira S, Domingues B, et al. Antibacterial effects ofAnodonta cygneafluids onEscherichia coliand enterococci multi-drug-resistant strains: environmental implications. Toxicol Environ Chem. 2014;96(6):880-9. doi: 10.1080/02772248.2014.989853.
  • 20. Ling TK, Xiong J, Yu Y, Lee CC, Ye H, Hawkey PM. Multicenter antimicrobial susceptibility survey of gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother. 2006;50(1):374-8. doi: 10.1128/AAC.50.1.374-378.2006. [PubMed: 16377716]. [PubMed Central: PMC1346789].
  • 21. Duttaroy B, Mehta S. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. India J Pathol Microbiol. 2005;48(1):45-8.
  • 22. Affolabi D, Sogbo F, Laleye G, Orekan J, Massou F, Kehinde A, et al. Rapid detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in blood cultures using the ESBL NDP test in Cotonou, Benin. J Med Microbiol. 2017;66(7):884-7. doi: 10.1099/jmm.0.000509. [PubMed: 28639543].
  • 23. Kim J, Lim YM. Prevalence of CTX-M extended-spectrum beta-lactamases in clinical isolates of enterobacteriaceae in Korea. J Bacteriol Virol. 2004;34(4):303-10.
  • 24. Eisner A, Fagan EJ, Feierl G, Kessler HH, Marth E, Livermore DM, et al. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria. Antimicrob Agents Chemother. 2006;50(2):785-7. doi: 10.1128/AAC.50.2.785-787.2006. [PubMed: 16436746]. [PubMed Central: PMC1366907].
  • 25. Mobin H, Nahaie M, Amir Mozafari N, Sadeghi J, Rasouli M. [Enterobacteriaceae producing extended-spectrum β-Lactamases (ESBL) and plasmid patterns in the intensive care unit of children's hospital in Tabriz]. Med J Tabriz Univ Med Sci. 2007;28:95-101. Persian.
  • 26. Samadi R, Eslami G, Baseri N, Zeynalfam R, Zeynali R. [Survey the prevalence of TEM genes and antimicrobial resistance among the Escherichia coli and Klebsiella pneumonia in patients with nosocomial infections in Shahid beheshti university hospitals in 2011]. New Cellular Molecular Biotechnol J. 2014;4(16):1-8. Persian.
  • 27. Mirzaee M, Pourmand M, Chitsaz M, Mansouri S. Antibiotic resistance to third generation cephalosporins due to CTX-M -type extended-spectrum β-lactamases in clinical isolates of Escherichia coli. Iran J Pub Health. 2009;38(1):10-7.
  • 28. Toth A, Juhasz-Kaszanyitzky E, Mag T, Hajbel-Vekony G, Paszti J, Damjanova I. Characterization of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006-2007. Acta Microbiol Immunol Hung. 2013;60(2):175-85. doi: 10.1556/AMicr.60.2013.2.8. [PubMed: 23827749].
  • 29. Sharma J, Sharma M, Ray P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res. 2010;132:332-6. [PubMed: 20847381].
  • 30. Nowroozi J, Akhavan Sepahi A, Tahmasebinejad Kamarposhti L, Razavipour R, Mazhar F. Evaluation of ciprofloxacin (gyrA, parC genes) and tetracycline (tetB gene) resistance in nosocomial Acinetobacter baumannii infections. Jundishapur J Microbiol. 2014;7(2). e8976. doi: 10.5812/jjm.8976. [PubMed: 25147676]. [PubMed Central: PMC4138684].
  • 31. Asadpour Rahimabadi K, Hashemitabar G, Mojtahedi A. [Antibiotic-resistance patterns in E. coli isolated from patients with urinary tract infection in Rasht]. J Guilan Univ Med Sci. 2016;24(96):22-9. Persian.
  • 32. Mirsalehian A, Nakhjavani F, Peymani A, JabalAmeli F, Mirafshar. S. M , Hamidian M. [Frequency of extended spectrum β-Lactamase producing Enterobacteriaceae in intensive care units]. Tehran Univ Med J. 2008;65(1):33-8. Persian.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments